Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 300

1.
2.

The treatment of negative symptoms: a clinical and methodological study.

Lapierre YD, Angus C, Awad AG, Saxena BM, Jones B, Williamson P, Vincent P, Carle R, Lavallee YJ, Manchanda R, Gauthier B, Wolf MA, Teehan MD, Denis JF, Malla AK, Oyewumi LK, Busse E, Labelle A, Claesson L, Grafford K.

Int Clin Psychopharmacol. 1999 Mar;14(2):101-12. Erratum in: Int Clin Psychopharmacol 1999 Sep;14(5):following 319.

PMID:
10220125
3.

Remoxipride and haloperidol in the acute phase of schizophrenia: a double-blind comparison.

Deo R, Soni S, Rastogi SC, Levine S, Plant I, Edwards JG, Mitchell M, Chanas A.

Acta Psychiatr Scand Suppl. 1990;358:120-4.

PMID:
1978470
4.

A double-blind comparative study of remoxipride and haloperidol in schizophrenic and schizophreniform disorders.

Mendlewicz J, de Bleeker E, Cosyns P, Deleu G, Lotstra F, Masson A, Mertens C, Parent M, Peuskens J, Suy E, et al.

Acta Psychiatr Scand Suppl. 1990;358:138-41.

PMID:
1978474
5.

Remoxipride and haloperidol in schizophrenia: a double-blind multicentre study.

Ahlfors UG, Rimön R, Appelberg B, Hagert U, Harma P, Katila H, Mahlanen A, Mehtonen OP, Naukkarinen H, Outakoski J, et al.

Acta Psychiatr Scand Suppl. 1990;358:99-103.

PMID:
1978501
6.
7.

Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparison.

Kane JM, Marder SR, Schooler NR, Wirshing WC, Umbricht D, Baker RW, Wirshing DA, Safferman A, Ganguli R, McMeniman M, Borenstein M.

Arch Gen Psychiatry. 2001 Oct;58(10):965-72.

PMID:
11576036
8.

A double blind comparative multicentre study of remoxipride and haloperidol in schizophrenia.

Andersen J, Kørner A, Ostergaard P, Fensbo C, Birket-Smith M, Thiesen S, Hansen NR, Fogh M, Kristensen M, Møller-Nielsen EM, et al.

Acta Psychiatr Scand Suppl. 1990;358:104-7.

PMID:
1978467
9.

A double-blind multicentre study comparing remoxipride, two and three times daily, with haloperidol in schizophrenia.

Laux G, Klieser E, Schröder HG, Dittmann V, Unterweger B, Schubert H, König P, Schöny HW, Bunse J, Beckmann H.

Acta Psychiatr Scand Suppl. 1990;358:125-9.

PMID:
1978471
10.

A double-blind comparative multicentre study of remoxipride and haloperidol in schizophrenia.

Lindström LH, Wieselgren IM, Struwe G, Kristjansson E, Akselson S, Arthur H, Andersen T, Lindgren S, Norman O, Naimell L, et al.

Acta Psychiatr Scand Suppl. 1990;358:130-5.

PMID:
1978472
11.

A double-blind multicentre study comparing remoxipride, controlled release formulation, with haloperidol in schizophrenia.

Pflug B, Bartels M, Bauer H, Bunse J, Gallhofer B, Haas S, Kanzow WT, Klieser E, Küfferle B, Stein D, et al.

Acta Psychiatr Scand Suppl. 1990;358:142-6.

PMID:
1978475
12.

Stability of neurological signs with clozapine treatment.

Buchanan RW, Koeppl P, Breier A.

Biol Psychiatry. 1994 Aug 1;36(3):198-200. No abstract available.

PMID:
7948457
13.

A double-blind comparative study of remoxipride and haloperidol in acute schizophrenia.

den Boer JA, Ravelli DP, Huisman J, Ohrvik J, Verhoeven WM, Westenberg HG.

Acta Psychiatr Scand Suppl. 1990;358:108-10.

PMID:
1978468
15.

A double-blind multicentre comparison of remoxipride, at two dose levels, and haloperidol.

Patris M, Agussol P, Alby JM, Brion S, Burnat G, Castelnau D, Deluermoz S, Dufour H, Ferreri M, Goudemand M, et al.

Acta Psychiatr Scand Suppl. 1990;358:78-82.

PMID:
1978497
16.

Clinical and neurocognitive effects of clozapine and risperidone in treatment-refractory schizophrenic patients: a prospective study.

Lindenmayer JP, Iskander A, Park M, Apergi FS, Czobor P, Smith R, Allen D.

J Clin Psychiatry. 1998 Oct;59(10):521-7.

PMID:
9818633
17.

Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia.

Breier A, Buchanan RW, Kirkpatrick B, Davis OR, Irish D, Summerfelt A, Carpenter WT Jr.

Am J Psychiatry. 1994 Jan;151(1):20-6.

PMID:
8267129
18.

Clinical predictors of response to clozapine treatment in ambulatory patients with schizophrenia.

Umbricht DS, Wirshing WC, Wirshing DA, McMeniman M, Schooler NR, Marder SR, Kane JM.

J Clin Psychiatry. 2002 May;63(5):420-4.

PMID:
12019667
19.

A double-blind comparative multicentre study of controlled-release remoxipride, immediate-release remoxipride and haloperidol in schizophrenia.

Hebenstreit GF, Laux G, Schubert H, Beckmann H, Amman J, Bunse J, Eikmeier G, Geretsegger C, Kanitz RD, Kanzow WT, et al.

Pharmacopsychiatry. 1991 Sep;24(5):153-8.

PMID:
1685572
20.

A double-blind controlled study of adjunctive treatment with risperidone in schizophrenic patients partially responsive to clozapine: efficacy and safety.

Anil Yağcioğlu AE, Kivircik Akdede BB, Turgut TI, Tümüklü M, Yazici MK, Alptekin K, Ertuğrul A, Jayathilake K, Göğüş A, Tunca Z, Meltzer HY.

J Clin Psychiatry. 2005 Jan;66(1):63-72.

PMID:
15669890

Supplemental Content

Support Center